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Summary 
Two waves of immunoglobulin gene rearrangements, 
first of the heavy, then of the light chain gene loci form 
functional immunoglobulin genes during B cell devel- 
opment. In mouse bone marrow the differential surface 
expression of 8220 (CD45R), c-kit, CD25 and surro- 
gate light chain as well as the cell cycle status allows 
FACS separation of the cells in which these two waves 
of rearrangements occur. The gene products of two 
recombination activating genes, RAG7 and RAG2 are 
crucial for this rearrangement process. Here, we show 
that the expression of the RAG genes is twice up- and 
down-regulated, at the transcriptional level for RAG7 
and RAGP, and at the postranscriptional level for RAG2 
protein. Expression levels are high in D -, JH and 
VH -+ DJH rearranging proB and preB-I cells, low in preB 
cells expressing the preB cell receptor on the cell sur- 
face, and high again in VL -, JL rearranging small preB-II 
cells. In immature B cells expressing on the cell sur- 
face RAG1 and RAG2 mRNA is down-regulated, 
whereas RAG2 protein levels are maintained. Down- 
regulation of RAG7 and RAG2 gene expression after 
productive rearrangement at one heavy chain allele 
might be part of the mechanisms that prevent further 
rearrangements at the other allele. 
Introduction 
During precursor B cell development germline DNA seg- 
ments of the immunoglobulin gene loci are joined by a 
site-specific recombination process to form functional 
genes. The gene products of two recombination activating 
genes, RAG7 and RAGP, are crucial for this rearrangement 
process (Schatz et al., 1989; Oettinger et al., 1990; Mom- 
baertset al., 1992; Shinkaiet al., 1992).Theimmunoglobu- 
lin heavy (H) chain locus is transcribed and rearranged 
before the immunoglobulin light (L) chain loci (Alt et al., 
1984, Lennon and Perry 1990). Whenever a functional 
VHDJH rearrangement has occurred in a precursor (pre) 
B cell, that cell will express a preB cell receptor on the 
surface, which is formed by the membrane-bound PH 
chain in complex with the surrogate L chain (Karasuyama 
et al., 1994; Rolink et al., 1994, Winkler et al., 1995). The 
surrogate L chain is composed of two proteins encoded 
by the preB cell-specific Vpre-B and 15 genes (Sakaguchi 
and Melchers, 1986; Kudo and Melchers, 1987). Less than 
1% of all preB cells and later stages of immature and 
mature B cells express two productivelyVHDJH-rearranged 
H chain gene loci (Kitamura and Rajewsky, 1992; Ehlich 
et al., 1994) an observation termed allelic exclusion of 
the expression of the H chain locus. 
The preB cell receptor is involved in the selection and 
amplification of preB cells by signaling the proliferative 
expansion of preB cells that have succeeded in a func- 
tional VHDJH rearrangement (Karasuyama et al., 1994; Rol- 
ink et al., 1994). The expression of the membrane-bound 
uH chain also mediates allelic exclusion by turning off 
VH to DJH rearrangements at the second H chain allele 
(Kitamura and Rajewsky, 1992; Ehlich et al., 1994). It is 
not clear at the present time whether surrogate L chain 
in a preB cell receptor participates in signaling allelic ex- 
clusion (Kitamura et al., 1991). 
In mouse bone marrow the expression of the tyrosine 
kinase c-kit and the interleukin-2 receptor a chain (CD25) 
distinguishesc-kit’CD25-proBandpreB-I cellsfrom c-kit- 
CD25’ preB-II cells (Rolink et al., 1994; Chen et al., 1994; 
see Rolink et al., 1994, for a comparison of nomenclatures 
used in preB cell development by different laboratories). 
PreB-II cells can further be subdivided into large cycling 
cells and small resting cells. The preB receptor is exclu- 
sively expressed on a fraction of large cycling preB-II cells. 
It is specifically recognized by a monoclonal antibody 
(MAb) named SL156, which binds to surrogate L when it 
is associated with PH chains, but not when it is free or 
associated with a complex of glycoproteins (gp130, gp 
35-65) (Karasuyama et al., 1993; Winkler et al., 1995). 
Expression of the preB receptor defines the boundary be- 
tween the early proB and preB-I cell stages with immuno- 
globulin genes in germline or DJH configuration, respec- 
tively, and large preB-II cells with a productive VHDJH 
rearrangement (Melchers et al., 1994; Winkler et al., 
1995). 
Various analyses have suggested that a productive re- 
arrangement at one H chain allele mediates H chain allelic 
exclusion, i.e., prevents further VH to DJH rearrangements 
at the other allele (Alt et al., 1984; Weaver et al., 1985). 
This should occur at the earliest preB cell stage where a 
productively rearranged H chain locus becomes ex- 
pressed, i. e., in large cycling preB-II cells expressing the 
preB receptor. Part of the mechanisms to achieve allelic 
exclusion could be to turn off RAG expression transiently. 
This has prompted us to analyze the expression of RAG 
genes during early B cell developmental stages. 
Results 
Separation and Characterization of Different 
Developmental Stages of B Lineage Cells 
in Mouse Bone Marrow 
Cells of different stages of B cell development were sorted 
by fluorescence-activated cell sorting (FACS) from bone 
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marrow of normal young mice into six populations, all of 
them expressing the pan B marker B220 (CD45R) on the 
cell surface. Table 1 summarizes the surface markers em- 
ployed in double and triple color FAGS to enrich for the 
different B lineage subpopulations. Details are given in the 
Experimental Procedures section. Representative FACS 
sorter data are shown in Figure 1. The purity of the differ- 
ent sorted cell fractions was between 960/o-98% after re- 
analysis. 
Table 1 also summarizes our knowledge of the expres- 
sion of other surface and intracellular markers in these B 
lineage subpopulations, determined in previous experi- 
ments (Rolink et al., 1994), and the status of re- 
arrangements in the immunoglobulin H and L chain gene 
loci previously determined in single cell polymerase chain 
reaction (PCR) analyses (Ten Boekel et al., 1995). 
Differential forward scatter analysis has been used to 
sort the 8220’ CD25 cells into large cycling and small 
resting cells. Previous experiments (Rolink et al., 1994; 
Winkler et al., 1995) have shown that approximately one- 
third of all large CD25+ cells express the preB cell receptor, 
while the rest of the large and the small 8220’ CD25 
cells do not express surrogate L chain. In the large cycling 
CD25 preB cells, the KL chain loci were found to be in 
germline configuration, while the small CD25+ preB cells 
have the L chain loci VLJL rearranged to the same extend 
as slg’ immature and mature 6 cells (Ten Boekel et al., 
1995). We therefore concluded that small resting CD25’ 
preB cells represent the later stage of development (Rolink 
et al., 1994). 
We analyzed RNA prepared from the different fractions 
semiquantitatively for the expression of genes known to 
be expressed in the B cell lineage by reverse transcription- 
PCR (RT-PCR). As shown in Table 1, only the earliest 
c-kit+ fraction of proB and preB-I cells expressed TdT, 
whereas RNA for h5 and VpreB (data not shown) was de- 
tected also in the large cycling preB-II cells. Sterile tran- 
scripts of the KL chain locus became detectable in the 
fraction of large CD25+ cells and were maximally ex- 
pressed in small CD25+ preB cells. The results confirm 
earlier analyses from our laboratory (Rolink et al., 1994) 
and suggest that TdT, involved in N-region insertions 
found in H, but not in L chain V(D)J joints, is turned off as 
soon as the H chain loci have been functionally rearranged 
and before L chain loci are rearranged. Surrogate L chain 
expression continues in large preB-II cells to ensure the 
expression of the preB receptor and is turned off before 
L chain gene rearrangements are induced. Transcription 
of the KL chain locus, as germline transcripts, precedes 
rearrangements, in agreement with earlier findings 
(Schlissel and Baltimore, 1989). 
Since large 8220’ SL156+ cells did not express sterile 
KL chain transcripts, while the large 822O+CD25“cellsdid, 
we conclude in agreement with earlier findings (Winkler et 
al., 1995) that the preB receptor-positive fraction repre- 
sents the intermediate stage between the c-kit+ proB/ 
preB-I and the large CD25’ preB-II cells. 
RAG Gene Expression Is Turned Down in PreB Cells 
Expressing the PreB Cell Receptor 
on the Cell Surface 
RNA levels for RAG7 and RAG2 were analyzed by a semi- 
quantitative RT-PCR assay (Figure 2). RT-PCR products 
of RNA expressed from a housekeeping gene, encoding 
hypoxanthine-guanine phosphoribosyl transferase (HPRT), 
served as controls for the quantity of RNA in the prepara- 
tion. RAG7 or RAG2 was coamplified in the same tube 
with HPRT. We found a bimodal RNA expression of RAG 
genes in the pre-6 cell fractions. Whereas the c-kit ex- 
pressing proB and pre-BI cells and the small CD25+ preB-II 
cells expressed high levels of both RAG? and RAG2 
mRNA, cells expressing the pre-B cell receptor on the 
surface were found to express barely detectable levels. 
The RT-PCR products of serial dilutions of the cDNA 
reaction were blotted and hybridized with radiolabeled 
probes and the hybridization signal was quantified by 
means of a Phosphorlmager. At constant levels of expres- 
sion of HPRT, RAG7 and RAG2 mRNA levels were at least 
Table 1. Development Stages of B Cell Differentiation Sorted for Analysis of RAG Expression 
Developmental stage pro6 and pm&l preB-II Immature B Mature B 
Cell surface marker used 
for sorting of 8220’ cells c-kit’ SL156’ Large CD25’ Small CD25’ IgM’ IgD- IgM’ IgD’ 
Cell cycle status’ 
Percent of cells in S, G2, or M 25-30 60-70 m-70 4 (5 <5 
Rearrangement statusb 
W DJ VDJ VDJ VDJ VDJ VDJ 
I@ GL GL GL VJJ, V.J, VJJ. 
VAJA Vdi Vdk 
Gene expression’ 
TdT +++ - - 
h5 +++ ++ + 
Sterile K light chain - ++ +++ ++ + 
a Cell cycle data were determined by 2-3 independent experiments. 
b Data were summarized from a study by ten Boekel et al. (1995). 
’ mRNA expression levels for TdT; 55, and a 0.8 kb sterile transcript from the KL chain locus were determined by semiquantitative AT-PCR. 
Pluses indicate relative expresison levels: three pluses, strong; two pluses, intermediate; one plus, weak. Minus indicates expresison levels below 
detection limits in this assay. 
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Figure 1. Flow Cytometric Analysis and Cell Sorting of Developmental Stages of B Lymphoid Cells in Bone Marrow from BDFl Mice 
Cells falling in the extended lymphoid gate are displayed. The percentages of cells within the rectangular sorter gates are shown in the figure. 
For A-C, bone marrow cells were depleted of slg’ cells before analysis and cell sorting. 
(A) Double staining with anti-B220 and anti-c-kit antibodies and sorting of c-kit’ proB/preB-I cells. For the analysis of RAG2 protein, double-positive 
cells were further fractionated according to forward light scatter characteristics (see Figure 4 for analysis of DNA contents). 
(B) Double staining with anti-B220 and SL156 and sorting of preB cell receptor-positive cells. 
(C) Double staining with anti-B220 and anti-CD25 and sorting of large and small CD25’ preB-II cells. 
(D) Triple staining with anti-B220, anti-IgM, and anti-IgD and sorting for IgM’lgD- immature B cells and IgM’IgD’ mature B cells. 8220’ B cells 
were gated. 
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Figure 2. Expression of RAG7 and RAG2 Genes at Different Stages of B Lineage Development 
B lineage cells of different developmental stages from bone marrow were sorted by FACS after dual or triple labeling, B220+ C~25+ cells were 
further subfractionated into large and small cells according to forward scatter characteristics. Equilibrated dilutions of cDNA transcribed from RNA 
of sorted cells were subjected to PCR amplification of individual genes with coamplification of the HPRT gene in the same reactions. After 
electrophoresis and Southern blotting, the PCR products were detected by hybridization with specific probes. 
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Figure 3. RAG2 Protein Expression in Fractionated Cells of Early B Cell Development 
Protein extracts from FACS-sorted cells from each fraction were analyzed by immunoblotting with affinity-purified polyclonal rabbit anti-RAG2 
antibodies. The stromal cell/IL-7dependent preB cell line BCL-2-5 expressing high levels of RAG2 protein after two days of in vitro culture in the 
absence of IL-7 (Rolink et al., 1993) served as a positive control, extracts from X53 myeloma cells were used as negative controls. Specificity of 
the antibodies was further verified by Western blot analysis of in vitro transcribed/translated RAG2 protein as well as analyzing extracts from 
RAGPT versus wild-type preB cell lines (data not shown). Protein loading was controlled by reprobing the blots for SS-B (La) protein with a human 
SLE serum. 
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30-to 70-fold lower in the SL156’fraction than in the c-kit+ 
fraction. 
In the fraction of the large CD25’ cells, which includes 
preB cell receptor-positive cells (Winkler et al., 1995) RAG 
gene expression was approximately 5 to lo-fold lower 
than in the small CD25’fraction. Low levels of expression 
were found in slgM+ immature 6 cells, while in mature B 
cells RAG expression was below detection levels. 
RAG2 Protein Levels in Cells at Different 
Developmental Stages of 
B Cell Differentiation 
RAG2 protein contents in total cell lysates from the sorted 
B cell populations were analyzed by Western blotting (Fig- 
ure 3). Interesting differences could be seen between 
mRNA expression and RAG2 protein content in the differ- 
ent B lineage subpopulations. In c-/&+ pro- and pre&I cells, 
as well as in small preB-II cells, high levels of mRNA ex- 
pression coincided with high RAG2 protein content. In the 
preB receptor-positive cells both mFiNA and protein was 
below detection limits. However, although RAG7 and 
RAG2 mRNA were already detectable in the large CD25’ 
preB-II cells, RAG2 protein remained undetectable in this 
cell fraction. On the other hand, the slgM+ immature B 
cells contained RAG2 protein levels as high as the small 
CD25’ preB-II cells, while RAG2 mRNA expression ap- 
peared to be considerably lower in immature B cells. 
These results either suggest that RAG2 mRNA and 
RAG2 protein have different turnover rates at different pre- 
cursor Bcell stages, orthat in large preB receptor-negative 
preB-II cells RAG2 mRNA expression is regained but pro- 
tein has not yet been made. Conversely, RAG2 mRNA 
expression is being turned off in immature B cells, while 
previously made RAG2 protein remains intact in these 
cells. 
RAG2 Protein Levels Fluctuate with the Cell Cycle 
in Early c-kit + ProB and PreB-I Cells 
It has been shown that RAG2 protein accumulates in the 
Gl phase within the cell cycle (Lin and Desiderio, 1994). 
This prompted us to assay for RAG2 protein content in 
different phases of the cell cycle of normal proB and preB-I 
cells isolated ex vivo (Figure 4). Since the majority of all 
c-kit+ proB and preB-I cells are in cell cycle, we sorted 
them by differential forward scatter analysis into small and 
large cells, the majority of which we found to be in the 
Gl , respectively, the SIG2IM phasesof the cell cycle. (Fig- 
ure 4A). Whereas small and large cells expressed similarly 
high levels of RAG7 and RAG2 mRNA (Figure 48) RAG2 
protein was detectable only in the small cells (Figure 4C). 
Thus, the regulated accumulation of RAG2 protein in Gl 
phase of the cell cycle can also be seen in normal proB and 
preB-I ‘cells of bone marrow within one developmentally 
homogeneous cell population. 
Discussion 
The bimodal up- and downmodulation of RAG gene ex- 
pression during B cell development is impressive in its 
extent. Expression is up in proB and preB-I cells, down 
in large preB receptor-positive preB-II cells, begins to 
come up again in large preB receptor-negative preB-II 
cells, is fully up again in small preB-II cells, is down- 
regulated to a large extent in immature B cells, and ap- 
pears to be off in mature B cells. 
Our measurements of RAG mRNA and RAG2 protein 
expression levels are limited on one side by the relative 
purity of thesubpopulationsof cellsand, on theother hand, 
by the relative stability of mRNA and protein that, in princi- 
ple, could be different at different stages of B cell develop- 
ment. If we consider that our FACS-purified preB cell popu- 
lations were at best 96%-98% pure, it is, however, all 
the more impressive that the large SL156’ preB-II cells 
express RAG7 and RAG2 mRNA and RAG2 protein at 
barely detectable levels. It might well be that RAG expres- 
sion is completely switched off in these cells and that the 
low level of mRNA detected in these cells is due to a con- 
tamination from, most likely, c-kit+ precursors expressing 
high levels of RAG genes. Furthermore, we show that the 
down-regulation of RAG7 and RAG2 mRNA expression in 
the SL156+ population is not merely correlated with their 
cell cycle status, since c-kit+ proB and preB-I cells enriched 
for cells in SIG2 or M showed high levels of RAG7 and 
RAG2 mRNA. 
Large preB receptor-negative preB-II cells were found 
to express RAG mRNA, whereas RAG2 protein was below 
detection limits. As others have described that RAG2 pro- 
tein, but not RNA levels, are decreased in cycling precur- 
sor lymphocytes that were enriched for cells in S, G2/M 
(Lin and Desiderio, 1994) this obviously applies to the 
large CD25+ fraction. These cells have, according to their 
developmental stage, regained RAG2 mRNA expression, 
but still display undetectable RAG2 protein levels, since 
600/o-70% of these cells are in S, G2/M (Table 1). 
Immature resting B cells showed very low levels of RAG 
mRNA, in agreement with earlier results by Li et al. (1993). 
RAG2 protein content, however, was found to be as high 
as in small pre&ll cells. This result might be expected if 
the RAG2 protein produced at high levels in the small 
CD25’ preB-II cells exerts a long half-life. The continued 
expression of RAG2 protein is compatible with recent find- 
ings that immature B cells may still continue to rearrange 
their L chain loci even when an immunoglobulin molecule 
isexpressedon thesurface(HaradaandYamagishi, 1991; 
Radic et al., 1993; Rolink et al., 1993; Tiegs et al., 1993). 
In a previous study, Li et al. (1993) have separated early 
stages of B cell development by means of differential ex- 
pression of CD43, HSA, and BP-1 on 8220’ cells (Hardy’s 
fractions A-F, Hardy et al., 1991). RAG mRNA expression 
was found to be high at all proB and preB cell stages 
(B-D). The great majority of the cells in fraction C, how- 
ever, have recently been found to be composed of nonpro- 
ductively VDJ rearranged preB cells (Ehlich et al., 1994). 
These data indirectly indicate that the cells need a produc- 
tive VHDJH to shut down RAG expression. The prediction 
would therefore be that the C’fraction (the CD43’ fraction 
of cells that has probably undergone productive VHDJH 
rearrangement and is cycling; Hardy et al., 1991) should 
be negative or very low for RAG expression. 
Stage-specific alterations in the steady-state levels of 
DNA content 
B 
RAG2 - 
HPRT - 
_._ 
C 
Cell Fraction c 
RAG-2 -W 
Figure 4. Cell Cycle-Dependent Regulation 
of BAG2 Protein but Not of RAG2 mRNA Accu- 
mulation in Early B Cell Progenitors Ex Vivo 
(A) DNA content of c-M+ and SL156’ preB cells 
after sorting. The percentage of cells in S, 62, 
or M is denoted in the histogram display. c-kit’ 
preB-I cells were subdiided into large and 
small cells according to forward scatter charac- 
teristics. 
(8) Expression of RAG2 mRNA analyzed in the 
sorted fractions by reverse transcription PCR. 
(C)Assay for BAG2 protein in sorted fractions. 
Cell extracts were analyzed for BAG2 protein 
and the SS-B (LA) protein by immunoblotting 
with a BAG2-specificantiserum orwith aserum 
from a patient wtth SLE as described in Figure 3. 
RAG7 mRNA during thymocyte development with low lev- 
els of RAG7 mRNA in late CD4- and CD8- cells have been 
described (Wilson et al., 1994). This developmental stage 
is likely to coincide with the expression of a newly re- 
arranged T cell receptor 8 chain, which is displayed on 
the surface with the pre-T a chain (Saint-Ruf et al., 1994). 
The inverse correlation of RAG gene expression with the 
expression of the pre-T cell receptor should be examined. 
Our results show that the expression of RAG7 and RAG2 
is tighly regulated during B cell development at the RNA 
level and that, in addition, RAG2 protein accumulation is 
regulated across the cell cycle. The data suggest that the 
presence of RAG mRNA and RAG2 protein coincides with 
immunoglobulin gene rearrangements, VDJ rearrange 
ments at the H chain gene locus in c-kit’ pro and preB-I 
cells and VJ rearrangements at the L chain gene loci in 
small CD25’ preB-II cells. These two waves of RAG gene 
expression are separated by a proliferative expansion 
phase of cells with a functional IgH gene rearrangement 
where the RAG7 and RAG2 RNA is down-regulated, and 
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RAG2 protein becomes undetectable. During the expan- 
sion phase, when recombination is transiently shut off, 
accessibility of the immunoglobulin gene segments might 
be controlled in a way that allows L chain gene re- 
arrangement and prevents further VH * DJH rearrange 
ments (Alt et al., 1992). The down-regulation of the tran- 
scription of RAG genes after productive immunoglobulin 
H chain rearrangement and during the proliferative expan- 
sion of pre&II cells might be part of the mechanisms that 
prevent further rearrangements at the other H chain allele 
until this second allele has become inaccessible for the 
recombination machinery. 
Experimental Procedures 
Mice 
Female 3 to 5-week-old (C578116J x DBAI2J)Fl mice were purchased 
from Biological Research Laboratories (Fiillinsdorf, Switzerland). 
RAG2Tmice(Shinkaietal., 1992)were bredatourownanimalfacilities 
from breeding pairsoriginallyobtainsdfrom Dr. F. Alt. Howard Hughes 
Medical Institute, Harvard Medical School, Boston. 
Antibodies 
The rat MAbs SL166 was established from fusions of X63-Ag6.663 
cells with spleen cells from rats immunized with purified mWVpre-B 
complex as described (Karasuyama et al., 1993; Winkler et al., 1995), 
purified, and conjugated with biotin by standard methods. The rat 
MAb ACK-4 (anti-mouse c-kit; Dgawa et al., 1991). provided by Dr. S. 
Nishikawa, and the rat anti-mouse IgD MAb NIM-R9 (Parkhouse et 
al.. 1992) provided by Dr. R. Parkhouse, were conjugated with biotin 
using standard procedures. The rat MAb M41 specific for mouse IgM 
(Leptin et al., 1964) was conjugated with fluorescein isothiocyanate 
or biotin using standard procedures. The fluorescein isothiocyanate- 
and APCconjugated MAb RA-6B2 (antiCD45R. 8220) and biotin- 
conjugated 7D4 (antiCD25. TAC) rat MAbs were purchased from Phar- 
mingen (San Diego, California). 
For the generation of polyclonal anti-RAG2 antibodies, amino acids 
70-516 of murine RAG2 were expressed in bacteria as a fusion protein 
with a mutant pseudomonasexotoxin (Bruggemann et al., 1991). Rab- 
bits were immunized with the partially purified fusion protein in 
Freund’s complete adjuvant and boosted with the immunogen in 
Fret&s incomplete adjuvant. Polyclonal antiserum was affinity puri- 
fied against the RAG2 polypeptide, expressed as a fusion protein with 
the maltose binding protein (pMAL, New England Biolabs). The gener- 
ation and purification of the antibody will be described in detail else- 
where (T. M. J. L. and D. G. S., unpublished data). 
Horseradish peroxidase(HRPO)-labeled polyclonal goat anti-rabbit 
IgG and HRPD-labeled goat anti-human IgG were purchased from 
Southern Biotechnical Associates, (Birmingham, Alabama). 
A human serum from a patient with systemic lupus erythematosus 
(SLE) containing high levels of anti-S&B (La) autoantibodies was a 
giftfrom Dr. J. R. Kalden, Institut. fur lmmunologie und Rheumatologie, 
Erlangen, Federal Republic of Germany. 
FACS Staining and Sorting 
Preparation of bone marrow cells from femurs, staining, and cell sort- 
ing was done as described (Rolink et al., 1994; Winkler et al., 1995). 
For the separation of the different preB cell stages, bone marrow cells 
were depleted of slgM’ cells using magnetic beads prior to staining 
as described (Winkler et al., 1995). Sorted cells were reanalysed after 
the sort and were batween 96%-96% pure. 
For the analysis of DNA content in the sorted fractions, the cells 
were fixed in 70% ethanol in phosphate-buffered saline for 30 min on 
ice, pelleted, and digested with RNase A (0.1 mg/ml) for 30 min at 
37°C and than stained with propidiumiodine (40 ug/ml). The cells were 
analyzed on a FACScan instrument (Becton Dickinson, Mountain 
View, California) with gating on fluorescence signal area versus signal 
width to exclude doublets. 
Kr-PCR 
Total RNA for cDNA synthesis was prepared using RNAzol B (Biotecx 
Laboratories, Incorporated, Houston, Texas) according to the recom- 
mendations of the manufacturers. RNA was reverse-transcribed using 
Superscript II reverse transcriptase (GIBCO Life Technologies. Gaith- 
ersburg, Maryland), 1 mM dNTPs, 1 ug random hexamericoligoncleo- 
tides, and the supplied buffer. RT-PCR assays wers carried out using 
the following primer pairs: RAG7, 5’-TGCAGACATTCTAGCACT- 
CTGG-3’. 5”ACATC TGCCTTCACGTCGAT-3’; RAGP, 5’-CTTCTCTA- 
GAGATTCCTGCTACCTCCCACC3’. 5’-TGTGGAATTCACTGCTGGG 
GTACCCAGGGG-3’; HPRT, 5’GCTGGTGAAAAGGACCTCT-3’, 5’-CA- 
CAGGACTAGAACACCTGC-3’. TdT, 5’-GAl-l-TCTAGACl-TGGTCCT- 
ClTCAlTlTGG-3’. B’CAAGGAAT-TCCCTC TGTGTCllTCAT GCT- 
G3’; W, 5%AGATCTAGACTGCAAGTGAGGCTAGAG3’, 5’-ClTGG- 
GCTGACCTAGGATTGS’; 0.6 kb sterile KL chain, S’CAGTGAGG- 
AGGGTll-t-TGTACAGCCAGACAG-3’. S’CTCATTCCTGTTGAAGC- 
TCTTGACAATGGG-3’. All PCRs were carried out with 1 cycle at 94OC 
for 40 s. followed by 30 cycles at 94OC for 20 s. at 55OC for 15 s, and 
at 72OC for 60 s. The following probes were used for PCR-Southern 
blot analysis: RAG7. a 950 bp fragment obtained by Hindlll digestion 
of MSBSK(+), containing the 5’region of RAG7 cDNA; RAG2, a 2100 
bp fragment obtained by Notl digestion of MRPBSK(+), containing 
the mouse RAG2 cDNA (Dattingar et al., 1990). The probes specific 
for the HPRT, TdT, Zi, and CK ganes were generated by cloning PCR 
fragments into Bluescript. 
The RT-PCR of the sorted fractions was repeated with samples 
from three different sorts of all B cell subpopulations and the results 
were comparable. 
In two experiments, the hybridization signals were quantftated by 
means of a Phosphorlmager equipped with ImageGuant software (Mo- 
lecular Dynamics. Mountain View, California). 
lmmunoblotting 
Total cellular protein was extracted from cells by lysing cells for 30 
min at 4OC in 0.5% deoxycholate, 1% NP-40, 0.1% SDS, 150 mM 
NaCI, 50 mM NaF, 50mM Tris-HCI (pH 6.0) containing 2.5 mM PMSF, 
2 @ml aprotinin, 2 pg./ml leupeptin, and 1 pg/ml pepstatin A. Cellular 
debris was removed by centrifugation at 12,000 x g at 4OC for 15 
min (Lin and Desiderio, 1993). Samples were diluted in reducing SDS- 
PAGE sample buffer and boiled for 5 min before electrophoresis on 
12% SDS-polyacrylamide gels. Western blotting was carried out as 
previously described (Grawunder et al., 1993). Blots were incubated 
with the affinity-purified polyclonal rabbit anti-RAG2 antibody (sea 
above) as primary reagent. Specific signals were revealed with HRPC- 
labeled polyclonal goat anti-rabbit IgG and an ECLdetection kit (Amer- 
sham International, Bucks, England) as recommended by the manu- 
facturer. For reprobing the filter, the HRPO on the filters was 
inactivated with phosphate-buffered saline, 10 mM NaN,, washed ex- 
tensively with phosphate-buffered saline-Tween, and incubated with 
a 1:5.060 dilution of the human autoimmune serum as a control for 
protein loading. 
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